23 May 2014
In general terms, engagement of private companies in the healthcare system on a competitive basis shall result in the price optimization and improvement of the quality of medical services provided and pharmaceuticals delivered to patients, Leonid Melamed, Chairman of the Board, Team Drive; Member of the Board of Directors, RusnanoMedInvest and NovaMedica said on Friday at St. Petersburg SPIEF2014.
22 May 2014
Russian pharmaceutical company “NovaMedica” won “Best Employer” prize as part of the National business award “Captains of the Russian Business”. The award winners are selected by the professional jury following the results of market experts’ opinion and companies’ activities survey over the past year.
25 March 2014
Leading Italian developer of innovative eye care solutions S.I.F.I. S.p.A. (SIFI) and Russian pharmaceutical company NovaMedica have entered into an exclusive commercial agreement for NovaMedica to market eight products developed and licensed by SIFI for the treatment of a wide range of ophthalmic pathologies in Russia and the CIS.
04 February 2014
NovaMedica Innotech, R&D unit of NovaMedica, a Russian pharmaceutical resident company of the Skolkovo Innovation Center, and Skolkovo Foundation signed the agreement to collaborate in building R&D center on the territory of Skolkovo Technopark.
19 December 2013
Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of products in the areas of topical pain and immunology, and NovaMedica LLC (NovaMedica), a Russian pharmaceutical company, today announced that they have signed a supply and distribution agreement providing NovaMedica the exclusive rights to market and sell Nuvo’s Pennsaid 1.5% and Pennsaid 2% products in Russia and some of the Community of Independent States (CIS).
11 December 2013
NovaMedica LLC, a Russian pharmaceutical company, and Venter Pharma SL, a Spanish company, developing innovative diagnostic systems, have signed a partnership agreement that grants NovaMedica exclusive rights to commercialize a new technology for the diagnosis of lactose intolerance, LacTEST®, in Russia and the Community of Independent States (CIS).
05 December 2013
NovaMedica LLC, a Russian pharmaceutical company, has signed a partnership agreement with Aptalis Pharma, a leading specialty pharmaceutical company, providing innovative, effective therapies for unmet medical needs, to develop and commercialize a portfolio of three of Aptalis Pharma’s novel gastrointestinal pharmaceutical products in Russia.
05 November 2013
NovaMedica is expected to launch its first portfolio products in H1 2014 and own developments are expected to launch in 1,5-2 years, - said Vladimir Gurdus, CEO of D-Pharma, Management Company of RusnanoMedInvest LLC and NovaMedica LLC at Pharma Russia Conference hosted by the newspaper “Vedomosti”.
31 July 2013
NovaMedica, a Russian pharmaceutical and medical device company, and ReVision Optics, Inc. the U.S. developer of the innovative refractive surgery solution against presbyopia Raindrop™ Near Vision Corneal Inlay, have signed an agreement to commercialize this technology in Russia.
25 July 2013
The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.
14 October 2021
14 October 2021
13 October 2021
13 October 2021